TrialJournal of diabetes investigation2019

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis.

Mads Svart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.